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HIV incidence in men who have sex with men (MSM) 
is increasing in western countries, including Portugal. 
We aimed to estimate HIV incidence and to assess how 
individual short-term changes in exposures over time 
predict seroconversion. We evaluated participants of 
an open cohort of HIV-negative MSM enrolled after 
testing at a community-based voluntary HIV counsel-
ling and testing centre in Lisbon. At each evaluation 
a structured questionnaire was completed and HIV 
status was ascertained using rapid followed by con-
firmatory testing. Between April 2011 and February 
2014, 804 MSM were followed for a total of 893 per-
son-years. Predictors of HIV seroconversion were 
identified using Poisson generalised linear regres-
sion. The overall seroincidence was 2.80/100 person-
years (95% confidence interval: 1.89–4.14). Men who 
seroconverted had a higher mean number of tests per 
year. Seroconversions were significantly associated 
with partner disclosure of HIV status during follow-
up, newly-adopted unprotected anal intercourse (UAI) 
with a steady partner and being newly-diagnosed with 
syphilis during follow-up. Likewise, sexual intercourse 
with HIV-positive men, having an HIV-positive steady 
partner at least once during follow-up and persis-
tent UAI with occasional partners were predictors of 
seroconversion. High HIV incidence in this cohort is 
likely driven by short-term contextual and behavioural 
changes during follow-up.
Introduction
A well-established body of potential strategies for 
the primary prevention of HIV infection stems from 
increased understanding of disease pathogenesis and 
transmission [1,2]. Still, there is evidence of grow-
ing HIV incidence among men who have sex with men 
(MSM) in western Europe, North America and Australia 
[3-8]. These trends are unlikely to be explained by 
changes in surveillance or testing practices [3], rather 
reflecting the fact that MSM remain at higher risk 
in most countries. This is apparent in the burden of 
newly-diagnosed infections in the European Union and 
European Economic Area: the largest fraction of HIV 
diagnoses reported in 2013 was attributable to sex 
between men (41.9%), followed by heterosexual trans-
mission (32.4%), and finally by unsafe injection prac-
tices (5.0%) [9].
This is also the Portuguese pattern: after several years 
of an HIV epidemic driven by unsafe drug injection, sex 
between men has gained special relevance as a trans-
mission mode making up 30.3% of all reported cases 
in 2013 [10]. Two pioneering cross-sectional stud-
ies [11,12] targeting MSM living in Portugal collected 
extensive self-reported information, leading to the first 
alarming estimates of the point prevalence of infec-
tion: 10.9% [13] and 10.3% (personal communication, A 
Gama, 2013).
Monitoring defined cohorts of MSM provides timely 
estimates of HIV incidence and predictors beyond 
the limited information produced by case reporting 
or cross-sectional surveys. In previous prospective 
cohorts, the occurrence of new infections has been 
modelled both as a function of factors that directly 
increase infection risk (frequency of unprotected anal 
intercourse (UAI), viral load of the index partner, pres-
ence of sexually transmitted infections (STI)), as well 
as potential markers of exposure, such as number of 
sex partners, substance use, and adverse childhood 
circumstances [14–19]. However, how individual expo-
sures change over time and how those changes can 
predict HIV seroconversion remains to be clarified.
Innovative community-based HIV testing and coun-
selling approaches have been developed that target 
specific population groups at higher risk and involve 
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community stakeholders as peer-counsellor and key 
informants [20]. As such, these are privileged settings 
for prospective research on the incidence and drivers 
of the HIV epidemic among MSM, with the ultimate 
goal of informing realistic preventive strategies.
The objectives of the present study were to estimate 
the incidence of HIV infection in a cohort of MSM and 
to assess how individual short-term changes in expo-
sures predict seroconversion.
Methods
Cohort recruitment and follow-up
The Lisbon MSM cohort, established in April 2011, 
is an observational prospective study conducted at 
a community-based voluntary HIV counselling and 
testing centre in Lisbon, Portugal (CheckpointLX). It 
was designed as an open cohort, and inclusion crite-
ria were: presenting for HIV testing at CheckpointLX, 
being a man aged 18 or more, reporting having sex 
with other men and having a negative HIV test result 
at recruitment. All eligible individuals were invited to 
enter the cohort by CheckpointLX peer counsellors at 
their first visit. Follow-up assessments were sched-
uled at intended intervals of 6 months, although the 
exact time between visits was adjusted according to 
the convenience of participants. Since follow-up visits 
occurred whenever clients decided to appear for test-
ing, this does not strictly constitute an interval cohort 
and it is likely that a small proportion of MSM had very 
short or long periods between visits: e.g. in our sam-
ple, 6.3% of men had follow-ups shorter than three 
months. This is problematic for MSM who seroconvert 
between tests which are close in time (due to possi-
ble window period), which is why we opted to exclude 
five participants with seroconversions that occurred 
during follow-up periods of less than three months. 
At each visit a structured questionnaire was adminis-
tered and a rapid HIV test was performed by a trained 
CheckpointLX peer counsellor. All participants gave 
their written informed consent and the study protocol 
was approved by the ethics committee of Hospital de 
São João and Medical School, University of Porto (ID 
104/12).
Participation and losses to follow-up
Data reported in this study refer to the period from April 
2011 to February 2014, during which 3,301 potential 
eligible individuals presented for testing, 195 (5.9%) of 
whom had an HIV-reactive test at entry and therefore 
were not included in the cohort. The remaining 3,106 
(94.1%) were eligible to the cohort. Among those, 
2,183 (70.3%) were enrolled, of whom 804 (36.8%) had 
at least one follow-up evaluation (893.37 person-years 
of observation) and 923 (29.7%) choose not to partici-
pate. Those who choose not to participate were less 
self-identified as homosexual, less frequently born in 
Portugal, and less educated than those who chose to 
participate, but had a similar proportion of HIV testing 
before cohort entry.
Operationally, participants were classified as lost to 
follow-up if they had chosen to participate but appeared 
for testing only once (n=707). However, MSM who had 
been recruited for the cohort recently (12 months or 
less before the end of the period considered in the 
present analysis, i.e. from February 2013 to February 
2014) were not considered lost to follow-up (n=672). 
Therefore, we assumed an overall attrition rate of 52%. 
MSM who were not followed-up were older than those 
who were (31.2 vs 30.3 years old, p=0.034), but both 
groups were similar regarding the remaining back-
ground characteristics. Also, no significant differences 
were found between MSM who appeared for follow-
up and those who did not regarding such behavioural 
characteristics as: sexual intercourse with HIV positive 
men (13.5% vs 12.9%, p = 0.955), having an HIV-positive 
steady partner (5.8% vs 5.2%, p = 0.528), and condom 
use with a steady partner (27.7% vs 27.9%, p > 0.999) 
and with an occasional partner in the previous 12 
months (57.1% vs 51.7%, p = 0.069).
Rapid HIV testing
Rapid HIV-1 and HIV-2 testing was performed at each 
visit. From April 2011 to April 2012 two commer-
cial kits were used, the Retrocheck HIV (QUALPRO 
DIAGNOSTICS, Goa, India) (manufacturer-described 
sensitivity = 100.00% and specificity = 99.75%) and 
Hexagon HIV (Human GmbH, Wiesbaden, Germany) 
(sensitivity = 100.00% and specificity = 99.50%) and 
since that time, only the Alere Determine HIV-1/2 (Alere 
Medical Co., Ltd. Chiba, Japan) (sensitivity = 100.00% 
and specificity = 99.75%) has been used. In case of a 
reactive test, an outpatient appointment was sched-
uled at Santo António dos Capuchos Hospital‘s HIV/
Infectious diseases clinic in Lisbon where a confirma-
tory test was performed. Pre- and post-test counselling 
was offered at each visit.
Study instruments and variables
Structured questionnaires were administered at entry 
and at each follow-up visit collecting data on back-
ground and behavioural characteristics, according to 
European Centre for Disease Prevention and Control 
(ECDC) [21] and the Joint United Nations Programme on 
HIV/AIDS (UNAIDS) guidelines [22] for HIV surveillance. 
For time-varying information the recall period was the 
previous 12 months (cohort entry questionnaire) or the 
time since the previous assessment (follow-up visits). 
Background characteristics included age, sex, country 
of birth, educational level and sexual identity.
Behavioural indicators included information on the fol-
lowing topics:
•	  History of previous HIV testing and reasons for 
index test;
•	  Age at first anal intercourse, role at anal inter-
course, characteristics of sexual partners (bisexual 
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men, men with different sexual partners, sex work-
ers, HIV-positive men, people who inject drugs, 
women and trios/group sex), steady (number, sex 
and HIV status) and occasional partners, having 
been paid for sex and venues used to meet occa-
sional partners;
•	  Frequency of condom use for anal intercourse with 
steady and occasional partners.
•	  Use of alcohol or recreational drugs (cannabis, 
lysergic acid diethylamide (LSD), poppers, heroin, 
ecstasy, amphetamines, mephedrone, gamma-
hydroxybutyric acid (GHB), ketamine and cocaine) 
before or during intercourse;
•	  Knowledge and use of non-occupational post-
exposure prophylaxis for HIV;
•	  History of other STI and hepatitis.
We were interested in assessing whether intraindividual 
changes over time in well-documented determinants 
of HIV incidence were predictive of seroconversion. 
Even though multiple changes in those determinants 
throughout follow-up were theoretically possible, we 
opted to use information collected at two time points 
for each participant: cohort entry and either the visit of 
the first HIV positive test (for MSM who seroconverted) 
or the most recent visit (for the remaining MSM). This 
choice was based on two main arguments: i) the major-
ity (53.8%) of participants had only two visits, and ii) 
for participants with three or more visits, using mul-
tiple combinations of information from all visits did 
not change the direction of associations or the main 
conclusions, i.e. first and last visit were good surro-
gates for exposure changes during follow-up (data not 
shown). For this purpose we created new variables for 
time-varying information that compiled responses from 
the first and the most recent visit, categorised as ‘Yes 
to No’ or ‘No to Yes’ if the information had changed 
between those visits, and ‘No and No’ or ‘Yes and Yes’ 
if answers were persistent. In case of 24 participants 
with more than two visits who preferred not to disclose 
one or more of the behavioural items at the most recent 
visit, we used the information obtained in the preced-
ing visit. This option did not alter substantially the 
magnitude of associations.
Statistical analysis
Characteristics of participants at cohort entry were 
described using absolute frequencies and proportions 
in the case of categorical variables. Means and stand-
ard deviation (SD) or median and percentiles 25 and 75 
(P25-P75) were used, as appropriate, to describe con-
tinuous variables. In data analysis, the missing cate-
gory was excluded from the denominator for each item. 
In time-varying information related to characteristics 
of sexual partners, the options ‘I do not know’ and the 
‘No’ options were collapsed once the incidence rates 
in both groups were similar. Unprotected anal inter-
course (UAI) was defined as not always having used 
a condom in receptive or insertive anal sex. Incidence 
rates with 95% confidence intervals (95% CI) were esti-
mated with time at risk defined as the period between 
recruitment and the most recent follow-up visit. In 
MSM who seroconverted, half of the period between 
the last HIV-negative test and the first HIV-positive test 
was subtracted.
Table 1A
Characteristics at entry of participants followed in the 
cohort of men who have sex with men, Lisbon, Portugal, 
2011–2014 (n=804)
Participants followed-up 804
Background characteristics
Age (years), mean (SD) 30.3 (8.9)
Missing 0
Sexual identity, n (%)
Homosexual 692 (86.1)
Bisexual/heterosexual/other 109 (13.6)
Prefer not to answer 3 (0.4)
Missing 0
Country of origin, n (%)
Portugal 575 (75.0)
Other country 190 (24.7)
Prefer not to answer 2 (0.3)
Missing 37
Educational level (schooling years), n (%)
Less than higher education (≤ 12 years of school) 317 (39.5)
Higher education (> 12 years of school) 483 (60.1)
Other/Prefer not to answer 3 (0.3)
Missing 1
HIV testing
Previous HIV testing, n (%)
No 115 (15.2)
Yes 636 (84.1)
Did not know 5 (0.7)
Missing 48
Number of previous testsa, median (P25-P75) 4 (2–7)
Missing 16
Reasons for index test, n (%) 
To check health status/routine 602 (77.9)
Perception of HIV exposure more than 3 months before 426 (54.0)
Perception of HIV exposure in the previous 3 months 357 (44.8)
Accident with condom use (rupture/left inside) 65 (8.4)
Partner diagnosed HIV+ /Disclosed HIV+ status 59 (7.6)
Possible window period by the time of the last test 55 (7.2)
To stop using condom with my partner 38 (5.0)
My partner asked me to test for HIV 34 (4.4)
Symptoms / Medical indication 20 (2.6)
a Among participants who had had a previous HIV test (n=636).
b Among participants who had a steady partner in the previous 12 
months (n=501).
c Among participants who had an occasional partner in the previous 
12 months (n=713).
d Among participants who had an HIV-positive steady partner 
(n=46).
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Table 1B
Characteristics at entry of participants followed in the cohort of men who have sex with men, Lisbon, Portugal, 2011–2014 
(n=804)
Participants followed-up 804
Sexual life and partners
Did not know 1 (0.1)
Prefer not to answer 3 (0.4)
Missing 13
Steady partner in the previous 12 months, n (%)
No 301 (37.4)
One steady partner 449 (55.8)
More than one steady partner 52 (6.5)
Prefer not to answer 2 (0.2)
Missing 0
HIV status of steady partnerb, n (%)
HIV negative 310 (62.5)
HIV positive 46 (9.3)
Did not know 139 (28.0)
Prefer not to answer 1 (0.2)
Missing 5
Occasional partners in the previous 12 months, n (%)
No 89 (11.1)
Yes 713 (88.7)
Prefer not to answer 2 (0.2)
Missing 0
Number of occasional partners in the previous 
12 monthsc, median (P25-P75) 5 (2–10)
Missing 19
Having sex for money or drugs in the previous 12 monthsc, n (%)
No 693 (97.3)
Yes 19 (2.7)
Missing 1
Venues used to meet occasional partnersc, n (%) 
Internet 522 (73.9)
Other venues (discos/gay bars, gym, outdoor 
cruising venues) 458 (57.6)
Only sexual venues (saunas, dark room, sex clubs) 166 (20.9)
Participants followed-up 804
Sexual life and partners
Age at first anal intercourse, median (P25-P75) 18.0 (16.0–21.0)
Missing 37
Role in anal intercourse, n (%)
Only insertive 192 (24.1)
Only receptive 72 (9.0)
Versatile 525 (66.0)
Prefer not to answer 7 (0.9)
Missing 8
Sex with at least one of the following in the previous 12 months, n (%)
Bisexual men
No 420 (53.1)
Yes 271 (34.3)
Did not know 98 (12.4)
Prefer not to answer 2 (0.2)
Missing 13
Men with different sex partners
No 148 (18.7)
Yes 588 (74.2)
Did not know 54 (6.8)
Prefer not to answer 2 (0.3)
Missing 12
Sex workers (even if not paid)
No 707 (89.4)
Yes 51 (6.4)
Did not know 31 (3.9)
Prefer not to answer 2 (0.3)
Missing 13
HIV-positive men
No 401 (50.7)
Yes 107 (13.5)
Did not know 281 (35.5)
Prefer not to answer 2 (0.3)
Missing 13
People who inject drugs
No 719 (90.9)
Yes 4 (0.5)
Did not know 65 (8.2)
Prefer not to answer 3 (0.4)
Missing 13
Women
No 690 (87.2)
Yes 99 (12.5)
Did not know 0
Prefer not to answer 2 (0.3)
Missing 13
Trios/group sex
No 563 (71.2)
Yes 224 (28.3)
a Among participants who had had a previous HIV test (n=636).
b Among participants who had a steady partner in the previous 12 
months (n=501).
c Among participants who had an occasional partner in the 
previous 12 months (n=713).
d Among participants who had an HIV-positive steady partner 
(n=46).
5www.eurosurveillance.org
Poisson generalised linear regression was used to 
identify predictors of HIV seroconversion with the 
default log link and offset in the variable follow-up 
time (t). To measure the magnitude of associations, 
crude and adjusted incidence rate ratios (IRR and 
aIRR) and respective 95% CI were computed. Variables 
whose regression coefficient through the Wald test had 
p < 0.10 in the univariate analyses were further adjusted 
for UAI with a steady partner and UAI with occasional 
partners to estimate their direct effects, even though 
we acknowledge that UAI may be an intermediate step 
in the causal mechanism. For the multivariate analy-
sis, significance level was set at p < 0.05. All statisti-
cal analyses were computed with Statistical Package 
for Social Sciences (SPSS) for Windows, version 22.0 
(SPSS Inc., Chicago, Illinois, US).
Results
Characteristics of participants at cohort entry
Background and behavioural characteristics at entry 
for the 804 participants who came for a follow-up visit 
between April 2011 and February 2014 are summarised 
in Table 1. Briefly, mean (SD) age was 30.3 (8.9) years; 
86.1% (692/804) of MSM self-identified as homosex-
ual; 75.0% (575/767) were born in Portugal and 60.1% 
(483/803) had over 12 years of schooling. HIV testing 
before cohort entry was reported by 84.1% (636/756) 
of participants. Slightly less than two thirds (501/804) 
of participants had at least one steady partner, of 
whom 9.3% (46/496) were in a serodiscordant couple. 
UAI with a steady partner in the year before cohort 
entry was reported by 72.4% (344/475); in particular, 
40.9% (18/44) of MSM who had an HIV-positive part-
ner had UAI in the same period; UAI with one or more 
occasional partners was reported by 43.7% (292/668) 
in the same period. Almost one third (238/790) of men 
reported having used recreational drugs before or dur-
ing sexual intercourse in the previous year. Over 2% 
(20/804) of MSM had a diagnosis of gonorrhoea during 
the previous 12 month, in the same period a little less 
than 2% (13/804) of MSM had a diagnosis of syphilis 
and 0.4% (3/804) were hepatitis C positive.
HIV incidence
Between April 2011 and February 2014, 804 MSM 
were followed for a total of 893.37 person-years (rang-
ing from six days to 2.84 years). During follow-up, 25 
seroconversions were recorded, yielding an overall 
incidence of 2.80 per 100 person-years (95% CI: 1.89–
4.14). From these 25 newly-identified cases, 19 (76.0%) 
were effectively linked to care via CheckpointLX. Of 
the remaining six individuals who did not accept refer-
ral, three preferred to use their own means to access 
health services and three did not provide information 
on clinical follow-up. Participants who seroconverted 
had a mean age of 31.2 (9.4) years: not significantly 
different from those who did not (30.2 (8.9) years, 
p = 0.598), and a significantly shorter average follow-
up time than those who did not seroconvert (0.79 years 
vs 1.12 years, p = 0.018), but approximately the same 
number of visits, resulting in a higher mean number of 
tests per year (4.8 vs 3.9, p = 0.012) (Table 2).
Table 1C
Characteristics at entry of participants followed in the 
cohort of men who have sex with men, Lisbon, Portugal, 
2011–2014 (n=804)
Participants followed-up 804
Unprotected anal intercourse (UAI), n (%)
UAI with a steady partner in the previous 12 monthsb
No 130 (27.4)
Yes 344 (72.4)
Prefer not to answer 1 (0.2)
Missing 26
UAI in the previous 12 months with an HIV-positive steady 
partnerd
No 26 (59.1)
Yes 18 (40.9)
Missing 2
UAI with occasional partners in the previous 12 monthsc
No 375 (56.1)
Yes 292 (43.7)
Prefer not to answer 1 (0.1)
Missing 45
Recreational drugs, n (%)
Used recreational drugs before or during sexual intercourse in 
the previous 12 months
Never 552 (69.9)
Always/often/occasionally/rarely 238 (30.1)
Missing 14
Post-exposure prophylaxis (PEP), n (%)
Does not know about PEP 411 (54.7)
Knows but never used 317 (42.2)
Knows and used 23 (3.1)
Missing 53
Sexually transmitted infections, n (%)
In the previous 12 months:
Gonorrhea 20 (2.5)
Syphilis 13 (1.6)
Condyloma or genital warts 10 (1.3)
Chlamydia 7 (0.9)
Genital herpes 1 (0.1)
Trichomonas 1 (0.1)
History of hepatitis, n (%)
Hepatitis B 18 (2.3)
Hepatitis C 3 (0.4)
a Among participants who had had a previous HIV test (n=636).
b Among participants who had a steady partner in the previous 12 
months (n=501).
c Among participants who had an occasional partner in the 
previous 12 months (n=713).
d Among participants who had an HIV-positive steady partner 
(n=46).
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Predictors of HIV infection
Being born before 1970 had a strong point estimate of 
association, though non-significant, with seroconver-
sion, whereas the remaining background indicators had 
negligible associations. Variables that were directly 
associated with HIV incidence even after adjustment 
for UAI were: reporting partner disclosure of HIV posi-
tive status between first and the most recent visit 
(aIRR=5.25; 95% CI 1.60–17.24; p=0.006); sexual inter-
course with HIV-positive men whether only reported at 
first visit (aIRR=3.79; 95%CI 1.17–12.24; p=0.026), or 
only at the most recent visit (aIRR=5.99; 95%CI 2.28–
15.71; p < 0.001); having had an HIV-positive steady 
partner at least once during follow-up (aIRR=3.28; 
95%CI 1.24–8.68; p=0.017); newly-adopted UAI with a 
steady partner regardless of their HIV status between 
cohort entry and the most recent visit (aIRR=3.85; 
95%CI 1.26–11.78; p=0.018); persistent UAI with occa-
sional partners during follow-up (aIRR=3.63; 95%CI 
1.38–9.58; p=0.009) and having been newly diagnosed 
with syphilis between cohort entry and HIV serocon-
version (aIRR=4.71; 95%CI 1.07–20.71; p=0.040).
Even though non-significant, having had sex with sex 
workers at least once during follow-up (aIRR=2.60; 
95%CI 0.92–7.36; p=0.072) and newly adopting UAI 
with occasional partners between cohort entry and 
the most recent visit (aIRR=2.79; 95%CI 0.87–8.92; 
p=0.084) were associated with HIV incidence. Crude 
associations with more generic markers of exposure 
(having started to have sex with men four to eight 
years before cohort entry, reporting recent sexual 
intercourse with bisexual men or women and persistent 
use of recreational drugs during follow-up) lost signifi-
cance after adjustments. Detailed results of HIV predic-
tors are presented in Table 3.
We stratified the analysis of the main determinants of 
HIV incidence by HIV status of steady partner (Figure). 
Overall, we observed that MSM who had an HIV-positive 
steady partner during follow-up had higher incidence 
rates than MSM who did not have an HIV-positive part-
ner. The greatest increases in HIV incidence were found 
for MSM reporting newly-adopted UAI with a steady 
partner (IRR = 17.29; 95% CI: 5.00–59.70) and MSM 
reporting persistent UAI with occasional partners dur-
ing follow-up (IRR = 14.19; 95% CI: 2.75–73.12).
Discussion
The Lisbon Cohort of MSM provides the first quantifica-
tion of HIV incidence in Portuguese MSM. The overall 
estimate of 2.80 per 100 person-years is higher than 
those obtained in other European settings [4,6,8], and 
shows worrying ongoing transmission of HIV among 
MSM, consistent with routine surveillance data [23].
In this cohort, having an HIV positive steady partner 
increased the risk of seroconversion, particularly after 
newly-adopted UAI with that partner and regardless of 
UAI with occasional partners. The role of serodiscord-
ant steady relationships in newly acquiring HIV infec-
tion is well-recognised [24]. Previous studies suggest 
that men within a steady relationship are more likely 
to engage in UAI and have lower rates of HIV testing as 
a result of lower risk perception and increased confi-
dence of remaining HIV-negative [25]. As for the timing 
of transmission, among MSM who seroconverted and 
had an HIV positive steady partner, approximately half 
reported their disclosure of HIV (whether previously 
diagnosed or not) during follow-up. This suggests 
that a substantial fraction of transmission to the index 
partner might occur during the acute infection stage 
of the steady partner, when the risk of transmission 
is highest [26]. Nevertheless, we cannot exclude the 
contribution of older infections. Indeed, 37.1% of HIV-
positive MSM in Portugal presented to care with CD4 
count < 350/mm3 and, and 39.0% either had detectable 
or unknown viral load [27].
Persistent UAI with occasional partners was associ-
ated with HIV seroconversion, as extensively described 
[28]. Our study adds that being newly diagnosed with 
Table 2
Comparison of follow-up time and number of visits between participants who seroconverted and those who did not, cohort 
of men who have sex with men, Lisbon, Portugal, 2011–2014 (n=804)
HIV-positive HIV-negative p valuea
N 25 779
Minimum and maximum of follow-up time 56 days – 1.91 years 6 days – 2.84 years n.a.
Mean time of follow-up (SD) (years) 0.79 (0.50) 1.12 (0.68) 0.018
Mean number of visits (SD) 2.76 (1.05) 2.85 (1.21) 0.816
Mean number of visits per year (SD) 4.8 (3.0) 3.9 (5.6) 0.012
n.a.: not applicable; SD: standard deviation.
a p value for independent samples, Mann-Whitney test
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Table 3a
Predictors of HIV incidence, cohort of men who have sex with men, Lisbon, Portugal, 2011–2014 (n=804)
HIV 
cases PY
HIV 
incidence IRR (95% CI) p value aIRR 
a (95%CI) p value
Mean number of tests per year during follow-up
Less than 2 1 166.74 0.6 1 1
2 5 367.90 1.4 2.27 (0.26–19.39) 0.455 3.40 (0.40–29.33) 0.266
3 6 215.20 2.8 4.65 (0.56–38.62) 0.155 4.70 (0.51–42.92) 0.170
4 3 83.49 3.6 5.99 (0.62–57.60) 0.121 10.59 (1.09–103.27) 0.042
More than 4 10 60.05 16.7 27.77 (3.56–216.92) 0.002 45.30 (5.62–365.00) < 0.001
Background characteristics
Birth cohort
Before 1970 5 109.26 4.6 2.81 (0.76–10.47) 0.123 n.a. n.a.
1970–1979 4 245.75 1.6 1 n.a.
1980–1989 12 373.74 3.2 1.97 (0.64–6.12) 0.239 n.a. n.a.
1990 or after 4 164.63 2.4 1.49 (0.37–5.97) 0.571 n.a. n.a.
Country of birth
Portugal 18 648.27 2.8 1 n.a.
Other 7 211.54 3.3 1.19 (0.50–2.85) 0.694 n.a. n.a.
Education (schooling years)
Less than higher education (≤ 12 years) 11 357.42 3.1 1.17 (0.53–2.58) 0.692 n.a. n.a.
Higher education (> 12 years) 14 533.74 2.6 1 n.a.
Sexual identity
Homosexual 22 789.81 2.8 1 n.a.
Bisexual/heterosexual/other 3 100.31 3.0 1.07 (0.32–3.59) 0.908 n.a. n.a.
HIV testing
Number of HIV previous tests at cohort entry
0 0 120.98 0.0 n.a. n.a. n.a.
1 to 5 14 476.42 2.9 1 n.a.
More than 5 10 234.47 4.3 1.45 (0.65–3.27) 0.368 n.a. n.a.
Reasons for HIV test during follow-up
Concerned with exposure to HIV throughout follow-up
   Never 2 163.21 1.2 1 n.a.
   At least once 22 716.67 3.1 2.51 (0.59–10.65) 0.214 n.a. n.a.
Partner was diagnosed with HIV/disclosed HIV status throughout follow-up
   Persistent No 18 758.15 2.4 1 1
   Changed: Yes to No 2 33.42 6.0 2.52 (0.58–10.86) 0.215 1.91 (0.24–15.01) 0.537
   Changed: No to Yes 5 38.48 13.0 5.47 (2.03–14.74) 0.001 5.25 (1.60–17.24) 0.006
   Persistent Yes 0 12.22 0.0 n.a. n.a. n.a. n.a.
Sexual life and partners
Age at first anal intercourse
More than 15 21 693.42 3.0 1 n.a.
15 or less 3 136.57 2.2 0.73 (0.22–2.43) 0.603 n.a. n.a.
Time since the beginning of sexual life with other men
4 years or less 5 238.32 2.1 1 1
4 to 8 years 10 185.97 5.4 2.56 (0.88–7.50) 0.086 2.57 (0.77–8.54) 0.123
more than 8 years 9 405.71 2.2 1.06 (0.35–3.16) 0.920 1.09 (0.32–3.70) 0.887
Role in anal sex
Insertive only 8 213.54 3.7 1 n.a.
Receptive/both 17 658.75 2.6 0.69 (0.30–1.60) 0.385 n.a. n.a.
aIRR: adjusted incidence rate ratio; CI: confidence interval; IRR: incidence rate ratio; n.a.: not applicable; PEP: post-exposure prophylaxis;  
PY: person-years; STI: sexually transmitted infection; UAI: unprotected anal intercourse.
a  Adjusted for UAI with a steady partner and UAI with occasional partners during follow-up.
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Table 3b
Predictors of HIV incidence, cohort of men who have sex with men, Lisbon, Portugal, 2011–2014 (n=804)
HIV 
cases PY
HIV 
incidence IRR (95% CI) p value aIRR 
a (95%CI) p value
Sexual life and partners
Sexual intercourse throughout follow-up with any of the following:
HIV-positive men
  Persistent No 11 672.50 1.6 1 1
  Changed: Yes to No 5 78.05 6.4 3.92 (1.36–11.27) 0.011 3.79 (1.17–12.24) 0.026
  Changed: No to Yes 8 74.57 10.7 6.56 (2.64–16.31) < 0.001 5.99 (2.28–15.71) < 0.001
  Persistent Yes 0 33.72 0.0 n.a. n.a.
Bisexual men
  Persistent No 10 478.84 2.1 1 1
  Changed: Yes to No 2 152.34 1.3 0.63 (0.14–2.87) 0.549 0.71 (0.15–3.32) 0.660
  Changed: No to Yes 3 79.66 3.8 1.80 (0.50–6.55) 0.370 2.23 (0.59–8.42) 0.236
  Persistent Yes 8 147.29 5.4 2.60 (1.03–6.59) 0.044 2.12 (0.79–5.66) 0.136
Men with different sexual partners
  Persistent No 3 113.13 2.7 1 n.a.
  Changed: Yes to No 5 194.75 2.6 0.97 (0.23–4.05) 0.965 n.a. n.a.
  Changed: No to Yes 2 85.45 2.3 0.88 (0.15–5.28) 0.891 n.a. n.a.
  Persistent Yes 13 462.90 2.8 1.06 (0.30–3.72) 0.929 n.a. n.a.
Sex workers (even if not paid)
  Never 18 779.22 2.3 1 1
  At least once 5 78.92 6.3 2.74 (1.02–7.39) 0.046 2.60 (0.92–7.36) 0.072
Women
  Persistent No 18 743.54 2.4 1 1
  Changed: Yes to No 4 64.21 6.2 2.57 (0.87–7.60) 0.087 2.22 (0.74–6.71) 0.156
  Changed: No to Yes 0 11.83 0.0 n.a. n.a. n.a.
  Persistent Yes 1 38.55 2.6 1.07 (0.14–8.03) 0.946 0.69 (0.09–5.34) 0.723
Trios/group sex
  Persistent No 13 508.19 2.6 1 n.a.
  Changed: Yes to No 0 129.60 0.0 n.a. n.a.
  Changed: No to Yes 3 84.82 3.5 1.38 (0.39–4.85) 0.613 n.a. n.a.
  Persistent Yes 7 134.39 5.2 2.04 (0.81–5.10) 0.129 n.a. n.a.
Steady partner during follow-up
Persistent No 5 180.52 2.8 1 n.a.
Changed: Yes to No 2 192.56 1.0 0.38 (0.07–1.93) 0.241 n.a. n.a.
Changed: No to Yes 4 145.44 2.8 0.99 (0.27–3.70) 0.992 n.a. n.a.
Persistent Yes 13 360.75 3.6 1.30 (0.46–3.65) 0.617 n.a. n.a.
HIV-positive steady partner during follow-up
Never 16 777.93 2.1 1 1
At least once 8 90.14 8.9 4.32 (1.85–10.08) 0.001 3.28 (1.24–8.68) 0.017
Occasional partners during follow-up
Persistent No 2 40.46 4.9 1 n.a.
Changed: Yes to No 2 146.52 1.4 0.28 (0.04–1.96) 0.198 n.a. n.a.
Changed: No to Yes 1 46.70 2.1 0.43 (0.04–4.78) 0.495 n.a. n.a.
Persistent Yes 18 644.85 2.8 0.56 (0.13–2.43) 0.443 n.a. n.a.
Number of occasional sexual partners in the previous 12 months at cohort entry
<  = 1 3 125.50 2.4 1 n.a.
2 to 9 12 408.48 2.9 1.30 (0.35–4.36) 0.749 n.a. n.a.
>  = 10 6 242.20 2.5 1.03 (0.26–4.14) 0.960 n.a. n.a.
Having sex for money or drugs during follow-up
Never 22 854.61 2.6 1 n.a.
At least once 1 21.84 4.6 1.78 (0.24–13.19) 0.573 n.a. n.a.
aIRR: adjusted incidence rate ratio; CI: confidence interval; IRR: incidence rate ratio; n.a.: not applicable; PEP: post-exposure prophylaxis;  
PY: person-years; STI: sexually transmitted infection; UAI: unprotected anal intercourse.
a  Adjusted for UAI with a steady partner and UAI with occasional partners during follow-up.
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Table 3C
Predictors of HIV incidence, cohort of men who have sex with men, Lisbon, Portugal, 2011–2014 (n=804)
HIV 
cases PY
HIV 
incidence IRR (95% CI) p value aIRR 
a (95%CI) p value
UAI during follow-up
UAI with a steady partner
Persistent No 5 305.85 1.6 1 1
Changed: Yes to No 4 191.38 2.1 1.28 (0.34–4.76) 0.714 1.10 (0.29–4.11) 0.892
Changed: No to Yes 10 150.54 6.6 4.06 (1.39–11.89) 0.010 3.85 (1.26–11.78) 0.018
Persistent Yes 5 194.26 2.6 1.57 (0.46–5.44) 0.473 1.83 (0.53–6.38) 0.340
UAI with occasional partners
Persistent No 7 388.18 1.8 1 1
Changed: Yes to No 0 148.83 0.0 n.a. n.a.
Changed: No to Yes 5 115.29 4.3 2.41 (0.76–7.58) 0.134 2.79 (0.87–8.92) 0.084
Persistent Yes 10 162.34 6.2 3.42 (1.30–8.97) 0.013 3.63 (1.38–9.58) 0.009
Venues used to meet occasional partners at cohort entry
Only sexual venues (saunas, dark rooms, sex clubs)
No 19 681.40 2.8 1 n.a.
Yes 6 195.90 3.1 1.1 (0.44–2.76) 0.841 n.a. n.a.
Other venues (discos/gay bars, gym and outdoor cruising venues)
No 10 368.51 2.7 1 n.a.
Yes 15 513.79 2.9 1.08 (0.48–2.40) 0.858 n.a. n.a.
Internet
No 6 313.65 1.9 1 n.a.
Yes 19 567.72 3.3 1.75 (0.70–4.38) 0.232 n.a. n.a.
STIs and hepatitis
Recent history of syphilis during follow-up
Persistent No 22 858.10 2.6 1 1
Changed: Yes to No 1 12.16 8.2 3.21 (0.43–23.79) 0.254 3.89 (0.47–31.91) 0.206
Changed: No to Yes 2 21.95 9.1 3.55 (0.84–15.12) 0.086 4.71 (1.07–20.71) 0.040
Persistent Yes 0 0.00 - - -
Recent history of gonorrhoea during follow-up
Persistent No 24 835.79 2.9 1 n.a.
Changed: Yes to No 0 25.77 0.0 n.a. n.a. n.a.
Changed: No to Yes 1 30.08 3.3 1.16 (0.16–8.56) 0.886 n.a. n.a.
Persistent Yes 0 0.00 n.a. n.a. n.a. n.a.
Lifetime history of hepatitis C reported at cohort entry
No/does not know 25 874.81 2.9 1 n.a.
Yes 0 2.76 0 n.a. n.a.
Lifetime history of Hepatitis B reported at cohort entry
No/does not know 24 862.89 2.8 1 n.a.
Yes 1 20.64 4.8 1.74 (0.24–12.88) 0.587 n.a. n.a.
Drug use before or during intercourse
Use of recreational drugs before or during intercourse during follow-up
Persistent No 9 507.25 1.8 1 1
Changed: Yes to No 2 91.08 2.2 1.24 (0.27–5.73) 0.785 0.92 (0.19–4.38) 0.915
Changed: No to Yes 5 117.90 4.2 2.39 (0.80–7.13) 0.118 1.63 (0.42–6.28) 0.477
Persistent Yes 8 155.99 5.1 2.89 (1.12–7.49) 0.029 1.90 (0.70–5.17) 0.209
PEP at cohort entry
Does not know about 14 437.41 3.2 1 n.a.
Knows about but never used 10 392.47 2.5 0.80 (0.35–1.79) 0.582 n.a. n.a.
Knows and used 1 21.15 4.7 1.48 (0.19–11.23) 0.706 n.a. n.a.
aIRR: adjusted incidence rate ratio; CI: confidence interval; IRR: incidence rate ratio; n.a.: not applicable; PEP: post-exposure prophylaxis;  
PY: person-years; STI: sexually transmitted infection; UAI: unprotected anal intercourse.
a  Adjusted for UAI with a steady partner and UAI with occasional partners during follow-up.
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syphilis during follow-up was a strong predictor of 
HIV incidence, independently of self-reported UAI. An 
additional red flag was the observation that MSM who 
seroconverted had shorter intervals between follow-up 
visits and higher mean number of tests per year, which 
highlights the use of testing as a risk management 
strategy.
Our findings suggest that, in addition to the pattern 
of service use itself, incident circumstances (newly-
adopted UAI with a steady partner, newly-disclosed 
HIV-positive partner, and newly-diagnosed syphilis) 
may be useful markers of the short-term risk of infec-
tion. Yet, it is important to note that we cannot assume 
that any incident circumstance or change in the infor-
mation provided between visits represents a sustained 
behavioural change but rather indicates varying behav-
ioural options that may influence seroconversion risk.
Other behavioural factors, such as time since the begin-
ning of sexual life, intercourse with bisexual men or sex 
workers and persistently using recreational drugs, may 
be regarded as less specific predictors of incident HIV, 
even though such effects were probably largely medi-
ated by UAI. The number of sexual partners in the year 
before cohort entry was not associated with increased 
HIV incidence. These findings highlight that, rather 
than extensively characterising the type or number of 
partners, targeted inquiries about UAI in this context 
seem to be more accurate for predicting HIV risk.
So far, none of the background variables predicted 
HIV risk in this cohort of Portuguese MSM. However, 
higher HIV incidence was found in MSM born before 
1970. Older MSM were previously described at higher 
risk of acquiring HIV from a steady partner [8] and may 
underestimate vulnerability since they have remained 
uninfected up to the present [29]. In contrast with pre-
vious studies and national and European surveillance 
data [5,30], younger MSM were not clearly identified as 
being at higher risk for HIV, but that could be related 
Figure
Stratified analysis of the main determinants of HIV incidence by HIV status of steady partner, cohort of men who have sex 
with men, Lisbon, Portugal, 2011–2014 (n=804) 
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to different patterns of use of the CheckpointLX by 
younger generations.
Methodological options and limitations of this study 
should be addressed. First, this design option is 
unlikely to result in a representative sample of the 
source MSM population, which limits the generalis-
ability of our findings. When compared with data from 
the 2007 National Health and Sexuality Survey (HSS) 
[31], MSM in our sample are younger, more self-identi-
fied as homosexual (86.1% vs 35.9% of men reporting 
some kind of sexual contact with men in the HSS) and 
report more frequently history of HIV testing (84.1% vs 
61.0% in HSS). Nevertheless, by setting up a cohort 
study in a community-based voluntary counselling 
and testing service we expect to reach MSM on aver-
age at higher risk of infection than the general MSM 
community. Thereby it seems reasonable to admit that 
we are focusing our attention on a priority subset of 
the population in terms of HIV risk (even if potentially 
more aware than those not reached by the service). 
Additionally, since CheckpointLX promotion strategies 
remained similar during follow-up, we do not expect 
that the extent of  selection bias will change substan-
tially over time, which is particularly important for esti-
mating secular trends of infection and behaviours in 
the source population [32-34]. Finally, the fact that the 
recruitment site is a service which aims to anticipate 
diagnosis and to provide evidence-based and adapted 
information may itself modify the risk of acquiring HIV 
and the consequent incidence estimates. However, we 
expect that newly-recruited clients reflect the overall 
incidence of infection in the community.
Another important issue is participation bias: the fact 
that around 30% of eligible MSM chose not to enter the 
cohort implies that informative data may be missing 
on a harder-to-reach subset of the target population. 
However, the frequency of prior testing was simi-
lar between groups, suggesting that both may have 
similar perceived risk of acquiring HIV [35]. Moreover, 
the observed attrition means that information about 
possible seroconversions is missing in half of partici-
pants, which is a clear limitation. Follow-ups depend 
on the frequency of service uptake, which can itself 
be influenced by perceived risk of infection. Efforts 
have been made to minimise dropout rates, including 
active reminders of follow-up visits by peer counsel-
lors. However, we still found differences in mean age 
between MSM who appeared for follow-up and those 
who did not, although the absolute difference was 
small. No differences were found in the frequency 
of behaviours associated with higher probability of 
seroconversion. This leads us to hypothesise that our 
incidence rate might not be substantially affected by 
losses to follow-up.
Self-reported information is always subject to limi-
tations in validity and reliability. However, we are 
confident that a relevant strength comes from the 
involvement of community peer counsellors, since this 
strategy increases participation and improves validity 
and completeness of information as well as disclosure 
of risk, as supported by previous research [34,36].
Despite the high incidence observed, the absolute 
number of infections is still low, resulting in subop-
timal statistical power for some comparisons. In the 
future, with larger sample size and longer follow-up 
periods, we expect increased precision of estimates. 
Nevertheless, these first estimates are important for 
two main reasons: i) they draw a first picture of HIV 
incidence and its drivers in Portuguese MSM about 
whom little was known; ii) they add evidence on the 
role of changes in individual circumstances in newly 
acquiring HIV to the existing body of prospective evi-
dence from a variety of settings.
In conclusion, we found high HIV incidence in this cohort 
of Portuguese MSM likely to be driven by short-term 
contextual and behavioural changes, namely newly-
adopted UAI with a steady partner, newly-disclosed 
HIV-positive partner and newly-diagnosed syphilis. 
History of serodiscordant steady relationships and per-
sistently reporting UAI with occasional partners also 
played a major role in predicting HIV seroconversion.
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